Abstract:In the current antiretroviral landscape, continuous efforts are still needed to search for novel chemotypes of human immunodeficiency virus type 1 (HIV-1) inhibitors with improved drug resistance profiles and favorable drug-like properties. Herein, we report the design, synthesis, biological characterization, and druggability evaluation of a class of non-nucleoside reverse transcriptase inhibitors. Guided by the available crystallographic information, a series of novel indolylarylsulfone derivatives were rationally discovered via the substituent decorating strategy to fully explore the chemical space of the entrance channel. Among them, compound 11h bearing the cyano-substituted benzyl moiety proved to be the most effective inhibitor against HIV-1 wild-type and mutant strains (EC50 = 0.0039-0.338 μM), being far more potent than or comparable to etravirine and doravirine. Besides, 11h did not exhibit cytotoxicity at the maximum test concentration. Meanwhile, the binding target of 11h was further confirmed to be reverse transcriptase (IC50 = 0.055 μM). Preliminary structure-activity relationship were discussed to guide further optimization work. Molecular docking and dynamics simulation studies were investigated in detail to rationalize the biological evaluation results. Further drug-likeness assessment indicated that 11h possessed excellent physicochemical properties. Moreover, no apparent hERG blockade liability and cytochrome P450 inhibition were observed for 11h. Notably, 11h was characterized by favorable in vitro metabolic stability with moderate clearance rates and long half-lives in human plasma and liver microsomes. Overall, 11h holds great promise as an ideal Anti-HIV-1 lead compound due to its potent antiviral efficacy, low toxicity, and favorable drug-like profiles.

Design, synthesis and antiviral activity of novel quinazolinones.

Design, Practical Synthesis, and Biological Evaluation of Novel 6-(Pyrazolylmethyl)-4-quinoline-3-carboxylic Acid Derivatives As HIV-1 Integrase Inhibitors

Design, synthesis and antiviral activity of novel pyridazines.

Design, Synthesis and Biological Evaluation of 3-Hydroxyquinazoline-2,4(1h,3h)-diones As Dual Inhibitors of HIV-1 Reverse Transcriptase-Associated RNase H and Integrase.

ChemInform Abstract: Design, Synthesis and Antiviral Activity of Novel Quinazolinones.

Design, Synthesis and Anti-HIV Integrase Evaluation of 4-Oxo-4h-quinolizine-3-carboxylic Acid Derivatives

Synthesis and Biological Evaluation of Novel Quinoxalinone-Based HIV-1 Reverse Transcriptase Inhibitors

Design,synthesis and activity evaluation of new anti-HIV-1 CXCR4 inhibitors

Synthesis and Biological Activities of Quinoline Derivatives As Hiv-1 Integrase Inhibitors

Design, Synthesis and Anti-Hiv Integrase Evaluation of N-(5-chloro-8-hydroxy-2-styrylquinolin-7-yl)benzenesulfonamide Derivatives.

Design, synthesis, and antiviral activities evaluation of novel quinazoline derivatives containing sulfonamide moiety

Rational design, synthesis, anti-HIV-1 RT and antimicrobial activity of novel 3-(6-methoxy-3,4-dihydroquinolin-1(2H)-yl)-1-(piperazin-1-yl)propan-1-one derivatives.

Arylazolyl(azinyl)thioacetanilide. Part 9: Synthesis and Biological Investigation of Thiazolylthioacetamides Derivatives As a Novel Class of Potential Antiviral Agents

Design and Discovery of 5-Hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide Inhibitors of HIV-1 Integrase

Synthesis and antiviral bioactivity of novel 3-((2-((1E,4E)-3-oxo-5-arylpenta-1,4-dien-1-yl)phenoxy)methyl)-4(3H)-quinazolinone derivatives.

Synthesis and antiviral bioactivities of 2-aryl- or 2-methyl-3-(substituted- benzalamino)-4(3H)-quinazolinone derivatives.

Structure-based design, synthesis, and biological characterization of indolylarylsulfone derivatives as novel human immunodeficiency virus type 1 inhibitors with potent antiviral activities and favorable drug-like profiles

Identification of Spirocyclic or Phosphate Substituted Quinolizine Derivatives As Novel HIV-1 Integrase Inhibitors: a Patent Evaluation of WO2016094197A1, WO2016094198A1 and WO2016154527A1

Quinolines and isoquinolines as HIV-1 inhibitors: Chemical structures, action targets, and biological activities

Synthesis of 6-Sulfamoyl-4-oxoquinoline-3-carboxylic Acid Derivatives As Integrase Antagonists with Anti-Hiv Activity

Synthesis and Biological Evaluation of Dihydroquinazoline-2-amines As Potent Non-Nucleoside Reverse Transcriptase Inhibitors of Wild-Type and Mutant HIV-1 Strains.